Clinical evaluation of the Cue's COVID‑19 diagnostic test to detect SARS‐CoV‐2 in the upper respiratory tract
- 28 April 2022
- journal article
- letter
- Published by Wiley in Journal of Medical Virology
- Vol. 94 (8), 3517-3519
- https://doi.org/10.1002/jmv.27805
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Rapid Diagnostic Testing for SARS-CoV-2The New England Journal of Medicine, 2022
- Diagnostics for COVID-19: moving from pandemic response to controlThe Lancet, 2021
- Point-of-care COVID-19 testing in the emergency department: current status and future prospectsExpert Review of Molecular Diagnostics, 2021
- COVID-19 Point-of-Care Diagnostics: Present and FutureACS Nano, 2021
- The ID NOW COVID-19, a high-speed high-performance assayEuropean Journal of Clinical Microbiology & Infectious Diseases, 2021
- Point-of-care testing detection methods for COVID-19Lab on a Chip, 2021
- Multicenter Evaluation of the Cepheid Xpert Xpress SARS-CoV-2/Flu/RSV TestJournal of Clinical Microbiology, 2021
- Evaluation of the Cue Health point-of-care COVID-19 (SARS-CoV-2 nucleic acid amplification) test at a community drive through collection centerDiagnostic Microbiology and Infectious Disease, 2021
- Comparison of the analytical sensitivity of seven commonly used commercial SARS-CoV-2 automated molecular assaysJournal of Clinical Virology, 2020
- Laboratory Diagnosis of COVID-19: Current Issues and ChallengesJournal of Clinical Microbiology, 2020